Neurofunctional Pain Management®

The pain relieving effect that occurs in the tissue, particularly in the pain neurons, is called sustained depolarization. In effect, the pain neurons become acclimated to a new homeostasis of being unpolarized and not reporting pain, creating a new normal of non-pain.

This also serves to reduce inflammation triggered by pain reporting neurons, thereby reducing the inflammation associated with pain conditions in a positive feedback loop. This positive feedback loop means reduced pain leads to reduced inflammation, which leads to reduced pain and so on.

The term for using high pulse electrical stimulation and electroanalgesia to reduce inflammation is called Electroionic® inflammation reduction or Electroionic® Therapy.

Electroanalgesia is an effective pain relief treatment that can endure even after the treatment has concluded. The duration of pain relief is related to the sustained depolarization effect that accumulates over multiple treatments.

For instance, a single treatment may last a few hours to a few days, whereas a course of regular treatments over several weeks can endure for months after completion. This is the reason longer treatment courses are recommended, preferably with multiple treatments occurring each week to obtain the desired cumulative pain relief effect.

Neuragenex®® protocols consist of two electroanalgesia treatments per week for twelve weeks, accompanied by a routine series of hydration therapy. This treatment combination and duration helps to create a relatively long-term pain relief effect that may last longer than most other methods of pain relief.

It has been a common occurrence for patients to experience relief for several months or even up to a year or more after completing their treatment. I have personally seen many patients experience long-term pain relief from a variety of chronic pain conditions, where the relief lasted over a year with no additional treatments or medications to prolong the effect.

Electroanalgesia is a specific and recognized medical term that is based on the electrical pulse per second capacity of the device used for the treatment, set according to the FDA clearance to perform that level of high pulsation.

Though many devices could be configured to reach the therapeutic pulse per second ranges of electroanalgesia, they are not authorized to be sold in the market in this manner. Extensive device trials are required for true FDA device approval in this treatment category, and to claim the ability to use the term electroanalgesia as a provider.

FDA device clearance for electroanalgesia is also required for Medicare and commercial insurance reimbursements, so any non-physician providers offering cash only treatments likely aren’t using a true electroanalgesia treatment or device.

Additionally, there is widespread confusion over what is, and what is not, an appropriate FDA cleared device for electroanalgesia treatment. Neurofunctional Pain Management® only uses 510k approved electroanalgesia devices that are FDA cleared for high pulse level therapy.

Electroanalgesia devices are allowed to modulate their cycles below electroanalgesia frequencies and back up, however other lesser devices are not allowed to do this. Instead, they must stay in the low power low pulse per second ranges where they are allowed
to operate.

For example, transcutaneous electrical nerve stimulation (TENS) devices are low power low pulse devices that are not able to deliver Neurofunctional Pain Management® as a TENS unit is not capable of reaching the pulse per second frequencies that qualify as electroanalgesia settings by the FDA.

Patients will often claim that they had a “similar” electrical treatment from their chiropractor or physical therapist. However, unless there was a genuine medical provider supervising the treatment, these are most likely low level TENS unit treatments that are not able to perform true electroanalgesia therapy.

In an attempt to circumvent the prohibited use of the official term electroanalgesia, which is not allowed to be used to describe TENS treatment, non-physician providers and device manufacturers have obfuscated the industry with other terms that are not recognized but which sound like high-tech medical terms.

Some of the terms used to circumvent the term electroanalgesia include electrical cell signaling, quantum specific resonance, frequency therapy, frequency healing, resonance therapy, and a variety of other terms using high-tech sounding words like quantum, frequency, and resonance.

While these terms attempt to create mystery, depth, and significance, hoping to drive sales to unsuspecting patients, the devices are still only classified as TENS units by the FDA.

The rubber meets the road when non-physician providers attempt to use these devices for reimbursement with Medicare or other commercial insurance companies, only to be denied and blocked by these payers as the devices and mysterious terminology are simply TENS units being described as something other than what they are.

Though non-physician providers using TENS units will heavily advocate that their treatment is “identical” or “the same as” true electroanalgesia treatments, they are not the same, nor do they produce the same effect, nor are they recognized by the FDA as electroanalgesia devices with 510k FDA certifications.

If your non-physician provider is claiming to offer a Neurofunctional Pain Management® treatment program, simply know that non-physician providers are not allowed to practice Neurofunctional Pain Management® as it is beyond their scope of practice. Instead, only seek authorized service providers of Neurofunctional Pain Management®. This is your first step in starting in the right place.